Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis

Genes Chromosomes and Cancer

Volumn 51, Issue 4, 2012, Pages 313-327

  Wu, Yuhsin V ^a   Okada, Tomoyo ^a   Decarolis, Penelope ^a   Socci, Nicholas ^a   O'Connor, Rachael ^a   Geha, Rula C ^a   Joy Somberg, C ^a   Antonescu, Cristina ^a   Singer, Samuel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL DEDIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DEDIFFERENTIATED LIPOSARCOMA; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOSARCOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WELL DIFFERENTIATED LIPOSARCOMA;

ADIPOCYTES; ADIPOSE TISSUE; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; LIPIDS; LIPOSARCOMA; NEOPLASMS, ADIPOSE TISSUE; PPAR GAMMA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84856777602     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21917     Document Type: Article

References (57)

1. Altiok S, Xu M, Spiegelman BM. 1997. PPARgamma induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 11: 1987-1998.
2. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho A, Chiang DY, Reva B, Mermel CH, Getz G, Antipin Y, Beroukhim R, Major JE, Hatton C, Nicoletti R, Hanna M, Sharpe T, Fennell TJ, Cibulskis K, Onofrio RC, Saito T, Shukla N, Lau C, Nelander S, Silver SJ, Sougnez C, Viale A, Winckler W, Maki RG, Garraway LA, Lash A, Greulich H, Root DE, Sellers WR, Schwartz GK, Antonescu CR, Lander ES, Varmus HE, Ladanyi M, Sander C, Meyerson M, Singer S. 2010. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 42: 715-721.
3. Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C. 2007. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res 67: 4657-4664.
4. Chan GK, Deckelbaum RA, Bolivar I, Goltzman D, Karaplis AC. 2001. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology 142: 4900-4909.
5. Costa DB, Dayaram T, D'Alo F, Wouters BJ, Tenen DG, Meyerson M, Tsao M-S, Halmos B. 2006. C/EBPα mutations in lung cancer. Lung Cancer 53: 253-254.
6. Cowherd RM, Lyle RE, McGehee RE, Jr. 1999. Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 10: 3-10.
7. Cram EJ, Ramos RA, Wang EC, Cha HH, Nishio Y, Firestone GL. 1998. Role of the CCAAT/enhancer binding protein-alpha transcription factor in the glucocorticoid stimulation of p21waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells. J Biol Chem 273: 2008-2014.
8. Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. 2006. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244: 381-391.
9. Dalal K, Antonescu C, Singer S. 2008. Diagnosis and management of lipomatous tumors. J Surg Oncol 97: 298-313.
10. Demetri GD, Fletcher CDM, Mueller E, Sarraf P, Naujoks R, Campbell N, Spiegelman BM, Singer S. 1999. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci U S A 96: 3951-3956.
11. Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Debril M-B, Miard S, Auwerx J. 2002. The retinoblastoma-histone deacetylase 3 complex inhibits PPARγ and adipocyte differentiation. Dev Cell 3: 903-910.
12. Fajas L, Egler V, Reiter R, Miard S, Lefebvre A-M, Auwerx J. 2003. PPARγ controls cell proliferation and apoptosis in an RB-dependent manner. Oncogene 22: 4186-4193.
13. Fawcett TW, Eastman HB, Martindale JL, Holbrook NJ. 1996. Physical and functional association between GADD153 and CCAAT/enhancer-binding protein beta during cellular stress. J Biol Chem 271: 14285-14289.
14. Francis GA, Fayard E, Picard F, Auwerx J. 2003. Nuclear receptors and the control of metabolism. Annu Rev Physiol 65: 261-311.
15. Fu M, Rao M, Bouras T, Wang C, Wu K, Zhang X, Li Z, Yao T-P, Pestell RG. 2005. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem 280: 16934-16941.
16. Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP. 2005. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin Cancer Res 11: 3184-3190.
17. Gimble J, Guilak F. 2003. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5: 362-369.
18. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. 2002. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 62: 528-534.
19. Han S, Roman J. 2007. Peroxisome proliferator-activated receptor gamma: A novel target for cancer therapeutics? Anticancer Drugs 18: 237-244.
20. Harris TE, Albrecht JH, Nakanishi M, Darlington GJ. 2001. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J Biol Chem 276: 29200-29209.
21. Hu E, Tontonoz P, Spiegelman BM. 1995. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc Natl Acad Sci U S A 92: 9856-9860.
22. Hu E, Kim JB, Sarraf P, Spiegelman BM. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274: 2100-2103.
23. Johnson PF. 2005. Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci 118: 2545-2555.
24. Koschmieder S, Halmos B, Levantini E, Tenen DG. 2009. Dysregulation of the C/EBPα differentiation pathway in human cancer. J Clin Oncol 27: 619-628.
25. Liu J, Farmer SR. 2004. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J Biol Chem 279: 45020-45027.
26. Loomis KD, Zhu S, Yoon K, Johnson PF, Smart RC. 2007. Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis. Cancer Res 67: 6768-6776.
27. Mariani O, Brennetot C, Coindre JM, Gruel N, Ganem C, Delattre O, Stern MH, Aurias A. 2007. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell 11: 361-374.
28. Meerarani P, Reiterer G, Toborek M, Hennig B. 2003. Zinc modulates PPARgamma signaling and activation of porcine endothelial cells. J Nutr 133: 3058-3064.
29. Miller SG, De Vos P, Guerre-Millo M, Wong K, Hermann T, Staels B, Briggs MR, Auwerx J. 1996. The adipocyte specific transcription factor C/EBPalpha modulates human ob gene expression. Proc Natl Acad Sci U S A 93: 5507-5511.
30. Park JO, Qin LX, Prete FP, Antonescu C, Brennan MF, Singer S. 2009. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: The one centimeter per month rule. Ann Surg 250: 977-982.
31. Porse BT, Pedersen TÅ, Xu X, Lindberg B, Wewer UM, Friis-Hansen L, Nerlov C. 2001. E2F repression by C/EBP[alpha] is required for adipogenesis and granulopoiesis in vivo. Cell 107: 247-258.
32. Rosen ED, Hsu C-H, Wang X, Sakai S, Freeman MW, Gonzalez FJ, Spiegelman BM. 2002. C/EBPα induces adipogenesis through PPARγ: A unified pathway. Genes Dev 16: 22-26.
33. Saladin R, Fajas L, Dana S, Halvorsen YD, Auwerx J, Briggs M. 1999. Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis. Cell Growth Differ 10: 43-48.
34. Schadinger SE, Bucher NL, Schreiber BM, Farmer SR. 2005. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab 288: E1195-E1205.
35. Schutte B, Reynders MM, van Assche CL, Hupperets PS, Bosman FT, Blijham GH. 1987. An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry 8: 372-376.
36. Shen H, Oesterling E, Stromberg A, Toborek M, MacDonald R, Hennig B. 2008. Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling. J Am Coll Nutr 27: 577-587.
37. Singer S, Antonescu CR, Riedel E, Brennan MF. 2003. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 238: 358-371.
38. Singer S, Socci ND, Ambrosini G, Sambol E, Decarolis P, Wu Y, O'Connor R, Maki R, Viale A, Sander C, Schwartz GK, Antonescu CR. 2007. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 67: 6626-6636.
39. Slomiany BA, D'Arigo KL, Kelly MM, Kurtz DT. 2000. C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol Cell Biol 20: 5986-5997.
40. Soriano HE, Kang DC, Finegold MJ, Hicks MJ, Wang ND, Harrison W, Darlington GJ. 1998. Lack of C/EBP alpha gene expression results in increased DNA synthesis and an increased frequency of immortalization of freshly isolated mice [correction of rat] hepatocytes. Hepatology 27: 392-401.
41. Tang QQ, Otto TC, Lane MD. 2003. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci U S A 100: 850-855.
42. Tang QQ, Zhang JW, Daniel Lane M. 2004. Sequential gene promoter interactions by C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis. Biochem Biophys Res Commun 318: 213-218.
43. Tavor S, Park DJ, Gery S, Vuong PT, Gombart AF, Koeffler HP. 2003. Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation. J Biol Chem 278: 52651-52659.
44. Taylor BS, DeCarolis P, Angeles CV, Brenet F, Schultz N, Antonescu CR, Scandura JM, Sander C, Viale AJ, Socci ND, Singer S. 2011. Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas. Cancer Discovery. doi: 10.1158/2159-8290.CD-11-0181.
45. Theocharis S, Margeli A, Vielh P, Kouraklis G. 2004. Peroxisome proliferator-activated receptor-γ ligands as cell-cycle modulators. Cancer Treat Rev 30: 545-554.
46. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. 1996. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 10: 804-815.
47. Timchenko NA, Wilde M, Darlington GJ. 1999. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice. Mol Cell Biol 19: 2936-2945.
48. Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CD, Brun RP, Mueller E, Altiok S, Oppenheim H, Evans RM, Spiegelman BM. 1997. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A 94: 237-241.
49. Wang G-L, Shi X, Salisbury E, Sun Y, Albrecht JH, Smith RG, Timchenko NA. 2006. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes. Mol Cell Biol 26: 2570-2582.
50. Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA. 2001. C/EBP[alpha] arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 8: 817-828.
51. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ. 1995. Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269: 1108-1112.
52. Willson TM, Brown PJ, Sternbach DD, Henke BR. 2000. The PPARs: From orphan receptors to drug discovery. J Med Chem 43: 527-550.
53. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, Spiegelman BM. 1999. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3: 151-158.
54. Xinqin K, Wei Z, Jie L, Zhenyuan S, Craig JM, Kang YJ, Zhanxiang Z. 2009. Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. Hepatology 50: 1241-1250.
55. Yoo EJ, Chung J-J, Choe SS, Kim KH, Kim JB. 2006. Down-regulation of histone deacetylases stimulates adipocyte differentiation. J Biol Chem 281: 6608-6615.
56. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, Reddy JK. 2003. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 278: 498-505.
57. Zuo Y, Qiang L, Farmer SR. 2006. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter. J Biol Chem 281: 7960-7967.